EUVIMEDEUVIMED entdecken
Crossref

Polyamine‐Depleting Hydrogen‐Bond Organic Frameworks Unleash Dendritic Cell and T Cell Vigor for Targeted CRISPR/Cas‐Assisted Cancer Immunotherapy

Yongchun Pan, Fei Zeng, Xiaowei Luan, Guanzhong He, Shurong Qin, Qianglan Lu, Bangshun He, Xin Han, Yujun Song iD

Advanced Materials · 2025-04 · 37 (13)

DOI: 10.1002/adma.202411886 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 19.02.2025. Verfasst von Yongchun Pan und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Engineering and Applied Sciences, State Key Laboratory of Analytical Chemistry for Life Science, National Laboratory of Solid State Micros…. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Dendritic Cells, Polyamines, Immunotherapy. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key R&D Program, Jiangsu Province Key R&D Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polyamines have tantalized cancer researchers as a potential means to rein in the rampant growth of cancer cells. However, clinical trials in recent decades have disappointed in delivering notable progress. Herein, a microfluidic‐assisted synthetic hydrogen‐bond organic framework (HOF) as a polyamine‐depleting nanoplatforms designed to unleash the vigor of both dendritic cells (DCs) and T cells for precision cancer immunotherapy is reported. Upon internalization by tumor cells, the loaded plasma amine oxidase (PAO) in HOF efficiently depletes polyamines, remolding the tumor microenvironment and alleviating T‐cell immunosuppression. This process also generates acrolein and H 2 O 2 , triggering CRISPR‐assisted neoantigen generation. Specifically, Acrolein induces carbonyl stress, increasing mutational burdens. Simultaneously, HOF leverages the energy from the bis[2,4,5‐trichloro‐6‐(pentyloxycarbonyl)phenyl] oxalate (CPPO)‐H 2 O 2 reaction for CRET‐triggered singlet oxygen production, leading to thioether bond cleavage and release CRISPR‐Cas9. Once released, CRISPR‐Cas9 knocks out the DNA mismatch repair (MMR)‐related MLH1 gene, further elevating mutational burdens and generating neoantigens, ideal targets for DCs. This dual‐action strategy not only corrects T‐cell immunosuppression but also enhances DC efficacy, presenting a powerful approach for tumor immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsDendritic CellsPolyaminesImmunotherapyT-LymphocytesNeoplasmsHumansAnimalsHydrogen BondingMiceCell Line, Tumor

Stichwörter der Autor:innen

CRISPR/Cas9hydrogen‐bond organic frameworkmicrofluidicneoantigenpolyamine depletion

Substanzen

Polyamines

Autor:innen und Institutionen

  • College of Engineering and Applied Sciences, State Key Laboratory of Analytical Chemistry for Life Science, National Laboratory of Solid State Microstructures, Nanjing University, Nanjing, 210023, China.
  • Department of Laboratory Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China.
  • School of Medicine & Holistic Integrative Medicine, JiangsuCollaborative Innovation Canter of Chinese Medicinal ResourcesIndustrialization, Nanjing University of Chinese Medicine, Nanjing, 210023, China.

ORCID-Profile: Yujun Song

Förderung

  • National Natural Science Foundation of China
  • National Key R&D Program
  • Jiangsu Province Key R&D Program
  • Jiangsu Province Innovative Talents and Entrepreneurs Program
  • State Key Laboratory of Analytical Chemistry for Life Science
  • Fundamental Research Funds for the Central Universities
  • Postgraduate Research & Practice Innovation Program of Jiangsu Province

Zitieren

APA

Pan, Y., Zeng, F., Luan, X., He, G., Qin, S., Lu, Q., He, B., Han, X., & Song, Y. (2025). Polyamine‐Depleting Hydrogen‐Bond Organic Frameworks Unleash Dendritic Cell and T Cell Vigor for Targeted CRISPR/Cas‐Assisted Cancer Immunotherapy. Advanced Materials, 37(13). https://doi.org/10.1002/adma.202411886

Vancouver

Pan Y, Zeng F, Luan X, He G, Qin S, Lu Q, et al. Polyamine‐Depleting Hydrogen‐Bond Organic Frameworks Unleash Dendritic Cell and T Cell Vigor for Targeted CRISPR/Cas‐Assisted Cancer Immunotherapy. Advanced Materials. 2025;37(13). doi:10.1002/adma.202411886

BibTeX
@article{Pan2025,
  author = {Pan, Yongchun and Zeng, Fei and Luan, Xiaowei and He, Guanzhong and Qin, Shurong and Lu, Qianglan and He, Bangshun and Han, Xin and Song, Yujun},
  title = {Polyamine‐Depleting Hydrogen‐Bond Organic Frameworks Unleash Dendritic Cell and T Cell Vigor for Targeted CRISPR/Cas‐Assisted Cancer Immunotherapy},
  journal = {Advanced Materials},
  year = {2025},
  volume = {37},
  number = {13},
  doi = {10.1002/adma.202411886}
}
Kostenlos starten →